A genetic test would be an improvement on current FDA-approved tests, which identify antibodies that can take weeks to emerge.
Scientists identify biomarkers that could help diagnose Lyme disease
A genetic test would be an improvement on current FDA-approved tests, which identify antibodies that can take weeks to emerge.